An interventional study of Participants will use 3D glasses to view VR educational information and routine care in Schizophrenia, sponsored by National Yang Ming Chiao Tung University. Not yet recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-21.
Sponsored by National Yang Ming Chiao Tung University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 181 studies in Schizophrenia with a site in Taiwan — 23 open to participants now, 26 under way, none of them phase 3. Schizophrenia · Taiwan.
Among the 181 studies in Schizophrenia with a site in Taiwan, this one is the 33rd largest by planned enrollment of the 153 interventional ones that give a count, is one of 8 that started in 2024, is one of 56 with no phase, reaches primary completion later than 9 of the 25 other live ones, and was the 166th registered.
3,574 studies on the registry are indexed under Schizophrenia; 494 are open to participants now.
Browse Schizophrenia studies →23 of the 181 studies in Schizophrenia with a site in Taiwan are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Taiwan, United States, Argentina and 4 more countries
Ages 18–55
China Medical University Hospital · Sites in Taiwan
Ages 20–65
Taipei Medical University Shuang Ho Hospital · Sites in Taiwan
Ages 20–70
China Medical University Hospital · Sites in Taiwan
Ages 18–65
National Taiwan University Hospital · Sites in Taiwan
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 333 Schizophrenia studies recruiting now, 63 (19%) set no upper age limit and 258 (77%) stop at 75 or younger; 42 take children under 18; 83 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
181 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 35 · Phase 3 41 · Phase 4 24
First in 2000; this study’s year is marked. 8 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 360 is above the median of 70 across 2,952 interventional studies indexed under Schizophrenia.
Median enrollment 85 across the 153 interventional studies, 110 across the 26 observational. Of the 129 that completed or were terminated, 34 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
59 of 181 have an industry lead sponsor. The 10 most frequent:
National Yang Ming Chiao Tung University is the lead sponsor of 208 studies on the registry; 58 are open to participants now.
National Yang Ming Chiao Tung University has 8 studies filed under Schizophrenia — fewer than ten, so there is no comparison to draw.
11 of the studies in Schizophrenia with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04917302China Medical University HospitalCombination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia | 2026-11 |
| NCT06563752National Yang Ming Chiao Tung UniversityExploring the Effectiveness of Digital Anti-stigma Therapy on Illness Perception and Perceived Stigma in Patients With Schizophrenia and Their Primary Caregivers | 2026-12 |
| NCT04959201China Medical University HospitalCombination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia | 2026-12 |
| NCT07781007Kaohsiung Kai-Suan Psychiatric HospitalEffectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia | 2026-12-02 |
| NCT05830903National Taiwan University HospitalDevelop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques | 2026-12-31 |
Add all 11 to your calendar (.ics) → With an account.
Among the 181 studies in Schizophrenia with a site in Taiwan, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to investigate the relationship between illness insight, self-stigma in patients with schizophrenia, and the awareness and associated stigma experienced by their families, as well as the predictors of these factors. The study will use information technology strategies for educational purposes, specifically employing 3D glasses for delivering this education. The goal is to develop a disease adaptation program that involves both patients and their families, helping to enhance disease awareness and improve stigma experiences.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patient group
Family group
Exclusion Criteria:
Patient group
(1) Patients with co-occurring personality disorders, substance or alcohol addiction, or organic brain damage; (2) Individuals living alone without close family contact; (3) Patients who will reside in a rehabilitation facility after discharge. Family group
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before discharge, provide routine discharge preparation instructions and offer a disease education booklet with relevant health information. Follow up with two phone calls after discharge, on the 7th and 30th days.
Other: routine care
The experimental group, referred to as the Dyad, involved both the caregiver and the patient wearing 3D glasses to watch educational VR content. The VR content included the following topics: 1. Understanding psychiatric symptoms, including symptoms, disease course, treatment, and prognosis. 2. Knowledge of medications and their relationship to symptom stability, as well as how to manage side effects. 3. Schizophrenia as a chronic illness, drawing comparisons to other chronic diseases. 4. Signs of disease relapse. 5. How to manage persistent psychotic symptoms of schizophrenia, such as delusions, hallucinations, paranoia, and negative symptoms. 6. How to interact and communicate with the patient. 7. Coping with stress, stress management, and suicide prevention. 8. Available resources.
Other: Participants will use 3D glasses to view VR educational information
Participants will use 3D glasses to view VR educational information, which includes: 1. Understanding of psychiatric symptoms, including symptoms, disease course, treatment, and prognosis. 2. Knowledge about medications, their relationship with symptom stabilization, and handling of side effects. 3. Schizophrenia as a chronic illness, with analogies to other chronic diseases. 4. Signs of disease relapse. 5. How to manage ongoing psychiatric symptoms of schizophrenia, including delusions, hallucinations, paranoia, and negative symptoms. 6. Strategies for interacting and communicating with patients. 7. Stress management and adjustment, as well as suicide prevention. 8. Available resources.
Before discharge, provide routine discharge preparation instructions and offer a disease education booklet with relevant health information. Follow up with two phone calls after discharge, on the 7th and 30th days.
Positive and Negative Syndrome Scale
This scale primarily assesses the severity of psychiatric disorders and was originally developed by Kay et al. (1987). It includes three dimensions: positive symptoms, negative symptoms, and general psychopathology, with a total of 30 items.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
The Schedule for the Assessment of Insight
This is a semi-structured interview questionnaire developed by David (1990), primarily used to assess illness insight and perceptions of the illness in psychiatric disorders. It includes three aspects: illness awareness, the importance of treatment, and disease recognition, with a total of 7 items.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
Internalized Stigma of Mental Illness
This scale primarily measures the subjective self-stigma experienced by individuals with mental illness and was developed in collaboration with patients. It includes 29 items across five dimensions: alienation, stereotype endorsement, perceived discrimination, social withdrawal, and anti-stigma coping ability.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
Medication Adherence Rating Scale
This self-report scale assesses patients' medication attitudes and adherence behaviors over the past week. It consists of 10 true/false questions, with scores ranging from 1 to 7 indicating poor adherence and 8 to 10 indicating good adherence.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
Drug Attitude Inventory-10
This is a self-report scale primarily used to assess patients' attitudes towards medication.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
Illness Perception Questionnaire-Revised Version for Families of Patients with Schizophrenia
This is a survey questionnaire designed to assess illness awareness among the family members of individuals with schizophrenia. It includes 38 items across 7 dimensions, evaluating participants' knowledge about schizophrenia and its management, causes, prevalence, prognosis, and treatment.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
Affiliate Stigma Scale
The primary purpose is to assess the caregiver's perception of internalized stigma. The scale consists of 22 items, covering three aspects: cognition, emotion, and behavior.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
Caregiver Burden Scale
The main purpose is to assess the burden level of caregivers of psychiatric patients. The scale contains 18 questions, measuring the actual problems and feelings that arise from caregiving. The scale includes five subdimensions.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
World Health Organisation- Five Well-Being Index
To assess the perception of Well-Being over the past two weeks.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
Multidimensional Scale of Perceived Social Support
To assess social support from different sources. The scale consists of 12 items across three dimensions: family, friends, and significant others.
Time frame: The assessment will be conducted three times: before the intervention, immediately after the intervention, and three months after the intervention.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Oct 2024; primary completion for Dec 2026, 26 months later.
Of 763 non-industry interventional studies with no phase under Schizophrenia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 56. This study's planned 26 months is below that.
Counting every sponsor, half of 776 studies reached it within 32 months; a quarter within 16 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Yang Ming Chiao Tung University →